{"id":"W2789648792","doi":"10.1097/hco.0000000000000518","title":"An update on trials of novel lipid-lowering drugs","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"AstraZeneca","keywords":"Medicine; Evolocumab; Canakinumab; PCSK9; Kexin; Cholesterylester transfer protein; Proprotein convertase; Population; Cholesterol; Internal medicine; Pharmacology; Coronary artery disease; Clinical trial; Statin; Lipoprotein; Disease; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006363281,0.001456037,0.00614621,0.003009679,0.0005327531,0.003913405,0.002464305,0.00432407,0.01114395],"category_scores_gemma":[0.01811828,0.0006045621,0.003066917,0.004008098,0.0007196438,0.003237485,0.001272836,0.003774511,0.00380463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001932721,"about_ca_system_score_gemma":0.004835852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00147316,"about_ca_topic_score_gemma":0.003746592,"domain_scores_codex":[0.99522,0.001510492,0.001435968,0.0003067841,0.001350762,0.0001759707],"domain_scores_gemma":[0.9842105,0.008875808,0.002521575,0.0002969143,0.003589143,0.0005060459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006877322,0.00006025233,0.0002142252,0.1954587,0.001055664,0.0001911039,0.00006583106,0.0001121537,0.0005293351,0.001712344,0.1702537,0.6296591],"study_design_scores_gemma":[0.0005188853,0.0002865359,0.001001386,0.1565439,0.003548635,0.000593392,0.00007589479,0.00005411231,0.0001976323,0.001292189,0.8358546,0.0000327697],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006322632,0.9934517,0.00008962522,0.002656706,0.002392387,0.0000540758,0.0001943285,0.00001814205,0.001079711],"genre_scores_gemma":[0.0008340671,0.98792,0.000470113,0.007301142,0.00238681,0.0001353371,0.0002894454,0.00001630095,0.0006467701],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01114395,"threshold_uncertainty_score":0.03728026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2310107588188999,"score_gpt":0.4738872178933312,"score_spread":0.2428764590744313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}